At a recent awards dinner I attended at the New York Academy of Sciences, James Allison told a captivated audience that his breakthrough cancer immunotherapy discoveries resulted not from focusing on cancer, but rather from his decades-long basic research to understand how the immune system works.
Weeks later, Allison and fellow immunologist Tasuku Honjo would be selected to receive last year’s Nobel Prize in Medicine.
For years, Allison and his colleagues studied a protein that serves as a brake on the immune system. They recognized that releasing this brake could unleash the immune system to attack and destroy tumors.
Independently, Honjo and colleagues identified another protein that performed a similar function.
These fundamental studies have now led to the development of new and powerful immunotherapies that are effective against cancer.
However, we still have much to learn. For some patients with some cancers, immunotherapy has been revolutionary, enabling people who had been on the verge of death to live healthy lives with no detectable traces of the disease. Yet the immunotherapy revolution is still in its infancy. For reasons that are still unclear, many cancers and patients simply do not respond.
Part of the problem, scientists increasingly agree, is the current lack of understanding of how the human immune system fights disease.
I have seen this firsthand, through decades of work trying to develop a vaccine for HIV/AIDS, a goal that has so far proved elusive.
That is why I believe the next breakthrough in foundational research will be decoding how the human immune system prevents and controls disease.
Artificial intelligence (AI) and machine learning will be the keys to this achievement, transforming the future of human health just as they are now changing other aspects of our lives.
The immune system — an intricate network of cells, tissues and organs — is the human body’s primary mechanism for staying healthy. Decoding it should be central to our efforts to understand and fight illness, whether non-communicable diseases such as cancer, diabetes and Alzheimer’s, or infectious ones such as tuberculosis, malaria and Ebola.
Over the past century, we have learned to engineer some aspects of our own immunity through vaccines, but we have reached a critical impasse. The threats we now face are much more insidious and complex, and each year millions of people — especially the very young, the elderly and those living in low and middle-income countries — die and suffer from diseases that should be conquered.
It does not have to be this way. By fully leveraging the power of our immune systems, we could find new ways to fight disease everywhere. We need new and creative ways of approaching the challenge across multiple disciplines — a coordinated effort on the moonshot scale of the Human Genome Project.
The good news is that such an undertaking is now possible. Recent technological advances in biomedicine, engineering and, most importantly, AI and machine learning, have given us the tools we need to embark on this ambitious endeavor.
Such tools are necessary because of the vast size and complexity of the human immune system. It is billions of times larger than the human genome, and processing such a huge amount of information requires significant data-science capabilities and frontier supercomputing. It also requires a major shift in how we approach clinical research studies.
Traditionally, clinical studies have focused on running tests across as many individuals as possible, collecting a limited amount of data on each subject. With the remarkable new genomics and molecular biology tools now available, researchers can collect millions of data points on a single individual. This is leading us to a new model: fewer people, much more data.
By merging AI and machine learning to analyze these individual data sets, we can better understand the molecular-level dynamics of the human immune system and start mapping its governing rules.
In early work being conducted through the Human Vaccines Project, scientists at the J. Craig Venter Institute, the San Diego Supercomputer Center and the University of British Columbia are using this approach to identify baseline biomarkers in individuals that predict immune responses to vaccines. Such work could pave the way for accelerating the development of novel vaccines and therapeutics for immune-mediated diseases.
Studies like these are starting to yield an unprecedented amount of data that ultimately will enable the creation of the first-ever atlas of the human immune system. Advances in frontier supercomputing can then be applied to that database to create the first AI-based models of the immune system. These models will fill in the current gaps in our knowledge to create more effective cancer immunotherapy, as well as diagnostics, vaccines and therapies for a host of other diseases.
I envision a world where scientists can rapidly develop new ways to fight disease; where vaccines provide lifetime protection for everyone, with a single immunization; where immunotherapy works for all cancers; and where Alzheimer’s is preventable.
To make this future a reality, we must merge creativity with continued advances in AI to crack the code of the human immune system.
Wayne Koff is president and chief executive officer of the nonprofit Human Vaccines Project.
Copyright: Project Syndicate
The EU’s biggest banks have spent years quietly creating a new way to pay that could finally allow customers to ditch their Visa Inc and Mastercard Inc cards — the latest sign that the region is looking to dislodge two of the most valuable financial firms on the planet. Wero, as the project is known, is now rolling out across much of western Europe. Backed by 16 major banks and payment processors including BNP Paribas SA, Deutsche Bank AG and Worldline SA, the platform would eventually allow a German customer to instantly settle up with, say, a hotel in France
On August 6, Ukraine crossed its northeastern border and invaded the Russian region of Kursk. After spending more than two years seeking to oust Russian forces from its own territory, Kiev turned the tables on Moscow. Vladimir Putin seemed thrown off guard. In a televised meeting about the incursion, Putin came across as patently not in control of events. The reasons for the Ukrainian offensive remain unclear. It could be an attempt to wear away at the morale of both Russia’s military and its populace, and to boost morale in Ukraine; to undermine popular and elite confidence in Putin’s rule; to
A traffic accident in Taichung — a city bus on Sept. 22 hit two Tunghai University students on a pedestrian crossing, killing one and injuring the other — has once again brought up the issue of Taiwan being a “living hell for pedestrians” and large vehicle safety to public attention. A deadly traffic accident in Taichung on Dec. 27, 2022, when a city bus hit a foreign national, his Taiwanese wife and their one-year-old son in a stroller on a pedestrian crossing, killing the wife and son, had shocked the public, leading to discussions and traffic law amendments. However, just after the
The international community was shocked when Israel was accused of launching an attack on Lebanon by rigging pagers to explode. Most media reports in Taiwan focused on whether the pagers were produced locally, arousing public concern. However, Taiwanese should also look at the matter from a security and national defense perspective. Lebanon has eschewed technology, partly because of concerns that countries would penetrate its telecommunications networks to steal confidential information or launch cyberattacks. It has largely abandoned smartphones and modern telecommunications systems, replacing them with older and relatively basic communications equipment. However, the incident shows that using older technology alone cannot
RSS